Plain-English translation of NCT07169630 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers want to understand whether a specific type of brain inflammation—measured by a protein called PDE4B—is higher in people with Alzheimer's disease or mild cognitive impairment. To find out, you would receive two specialized brain scans (PET scans) and one MRI scan, along with memory and thinking tests and blood draws. The scans use a harmless radioactive tracer to light up where this inflammation might be happening in your brain.
We still don't fully understand what causes memory loss and Alzheimer's disease. Scientists think brain inflammation may play an important role. This study is looking for a way to spot and measure that inflammation early, which could eventually help doctors diagnose and treat these conditions better.
You likely qualify if…
You likely don't qualify if…
You would visit the NIH for study appointments where you'll have two specialized brain imaging scans (PET scans) and one standard MRI scan, along with memory and thinking tests and blood work. The whole process takes several hours, and during the scans you'll need to lie still on a camera bed. You'll also be asked to avoid certain medications before your visit and follow some lifestyle guidelines. The study involves only observation and testing—no medication to take.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States